NCT02246114

Brief Summary

Our goal is to study self-monitoring of smoking as a means to reduce smoking in pregnant women. Investigators hypothesize that more regular self-monitoring, text messages and feedback as provided by home carbon monoxide monitoring device combined with medical feedback on results will reduce smoking during pregnancy compared to only receiving text message and no self-monitoring by home monitoring device and no feedback by home carbon monoxide monitoring device . The periconceptual period is a life period, where given the immediacy of the fetus and future child, a pregnant woman is willing to try and modify potentially harmful behaviors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started Sep 2014

Shorter than P25 for not_applicable pregnancy

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 22, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

January 16, 2017

Completed
Last Updated

January 16, 2017

Status Verified

November 1, 2016

Enrollment Period

8 months

First QC Date

September 15, 2014

Results QC Date

September 29, 2016

Last Update Submit

November 21, 2016

Conditions

Keywords

PregnancySmokingSmoking cessation

Outcome Measures

Primary Outcomes (1)

  • Primary Outcome of Serum Cotinine Levels

    The primary outcome is the difference in serum cotinine levels between the intervention and control groups at the end of the trial.

    1 year

Study Arms (2)

no CO monitor

EXPERIMENTAL

Not given a piCO+ Smokerlyzer® monitor, will receive daily text messages.

Other: Text messages

CO monitor

EXPERIMENTAL

Given a piCO+ Smokerlyzer® monitor, will receive daily text messages, will receive feedback about the relative level of carbon monoxide.

Device: piCO+ Smokerlyzer® monitorOther: Text messages

Interventions

CO monitorno CO monitor

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women 18-40 years old
  • Participants will be pregnant women estimated to be between 6 and 20 weeks into their pregnancy
  • Pregnant women have smoked at least at least one cigarette in the prior 7 days
  • Own a smartphone capable of delivering and receiving text messages

You may not qualify if:

  • Project materials and text messages are in English, potential participants will be excluded if they cannot read English and if there are concerns about the ability to comprehend or comply with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MS Hershey Medical Center, Penn State College of Medicine

Hershey, Pennsylvania, 17033, United States

Location

MeSH Terms

Conditions

SmokingSmoking Cessation

Condition Hierarchy (Ancestors)

BehaviorHealth Behavior

Limitations and Caveats

The study closed early due to lack of recruitment. Only 1 subject enrolled in the study and she terminated after the baseline visit due to a miscarriage at 9 weeks. Therefore no analysis has been performed.

Results Point of Contact

Title
Richard S. Legro, M.D.
Organization
The Milton S. Hershey Medical Center

Study Officials

  • Richard S Legro, MD

    Penn State College of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Obstetrics and Gynecology and Public Health Sciences

Study Record Dates

First Submitted

September 15, 2014

First Posted

September 22, 2014

Study Start

September 1, 2014

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

January 16, 2017

Results First Posted

January 16, 2017

Record last verified: 2016-11

Locations